Form 4: GE HealthCare Executive Acquires Shares and Options in Recent Transactions

Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., reports acquisition of shares and stock options, along with share withholding for tax obligations.

Summary

• Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., filed a Form 4 detailing changes in beneficial ownership.
• On March 1, 2024, shares were withheld to satisfy tax obligations related to vesting restricted stock units, with 6,443 shares withheld at $91.28 and another 4,841 shares withheld at $91.28.
• Also on March 1, 2024, Jimenez was awarded 9,437 restricted stock units (RSUs).
• These RSUs will vest in three tranches: 33% on September 1, 2025, 33% on September 1, 2026, and 34% on September 1, 2027, subject to certain conditions.
• Each RSU represents the right to receive one share of GE HealthCare common stock at settlement.
• Additionally, Jimenez was granted an employee stock option for 26,840 shares on March 1, 2024, exercisable in three tranches mirroring the RSU vesting schedule.
• The exercise price for the stock option is $92.72 per share, and the option expires on March 1, 2034.
• Following these transactions, Jimenez directly owns 74,481 shares of GE HealthCare common stock and options for 26,840 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The grants are positive for aligning management with shareholders, but the tax withholding is a neutral event.

Positives

• The grant of restricted stock units and stock options to a key executive aligns their interests with the long-term performance of the company.
• The vesting schedule of the RSUs and stock options (September 1, 2025, September 1, 2026, and September 1, 2027) encourages continued service and commitment from the executive.

Future Outlook

The document outlines future vesting dates for restricted stock units and stock options, indicating the executive's long-term stake in the company's performance.

Industry Context

Equity compensation is a common practice in the healthcare industry to incentivize executives and align their interests with shareholders. The vesting schedules are typical for retention purposes.

Comparison to Industry Standards

• Equity grants are a standard component of executive compensation packages across the S&P 500, including companies like Siemens Healthineers and Philips.
• Vesting schedules of three to four years are common to ensure executive retention and alignment with long-term shareholder value, similar to practices observed at Medtronic and Johnson & Johnson.
• The mix of stock options and restricted stock units is also typical, balancing the incentive for stock price appreciation with guaranteed equity ownership over time, a strategy also employed by Danaher and Abbott Laboratories.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign of aligning management's interests with the company's long-term success.
• Employees may see the executive's increased stake in the company as a sign of confidence in its future.

Key Dates